全文获取类型
收费全文 | 11680篇 |
免费 | 723篇 |
出版年
2023年 | 62篇 |
2022年 | 64篇 |
2021年 | 148篇 |
2020年 | 131篇 |
2019年 | 131篇 |
2018年 | 324篇 |
2017年 | 300篇 |
2016年 | 361篇 |
2015年 | 518篇 |
2014年 | 560篇 |
2013年 | 747篇 |
2012年 | 1063篇 |
2011年 | 1546篇 |
2010年 | 779篇 |
2009年 | 764篇 |
2008年 | 543篇 |
2007年 | 517篇 |
2006年 | 446篇 |
2005年 | 425篇 |
2004年 | 396篇 |
2003年 | 362篇 |
2002年 | 344篇 |
2001年 | 323篇 |
2000年 | 302篇 |
1999年 | 251篇 |
1998年 | 76篇 |
1997年 | 50篇 |
1996年 | 48篇 |
1995年 | 40篇 |
1994年 | 39篇 |
1993年 | 34篇 |
1992年 | 79篇 |
1991年 | 81篇 |
1990年 | 67篇 |
1989年 | 56篇 |
1988年 | 54篇 |
1987年 | 42篇 |
1986年 | 35篇 |
1985年 | 41篇 |
1984年 | 39篇 |
1983年 | 25篇 |
1982年 | 15篇 |
1981年 | 11篇 |
1980年 | 18篇 |
1979年 | 18篇 |
1977年 | 15篇 |
1975年 | 13篇 |
1973年 | 10篇 |
1972年 | 10篇 |
1968年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
941.
942.
943.
944.
945.
Jeffrey J. Perry Mukul Sharma Marco L.A. Sivilotti Jane Sutherland Cheryl Symington Andrew Worster Marcel ��mond Grant Stotts Albert Y. Jin Weislaw J. Oczkowski Demetrios J. Sahlas Heather E. Murray Ariane MacKey Steve Verreault George A. Wells Ian G. Stiell 《CMAJ》2011,183(10):1137-1145
Background:
The ABCD2 score (Age, Blood pressure, Clinical features, Duration of symptoms and Diabetes) is used to identify patients having a transient ischemic attack who are at high risk for imminent stroke. However, despite its widespread implementation, the ABCD2 score has not yet been prospectively validated. We assessed the accuracy of the ABCD2 score for predicting stroke at 7 (primary outcome) and 90 days.Methods:
This prospective cohort study enrolled adults from eight Canadian emergency departments who had received a diagnosis of transient ischemic attack. Physicians completed data forms with the ABCD2 score before disposition. The outcome criterion, stroke, was established by a treating neurologist or by an Adjudication Committee. We calculated the sensitivity and specificity for predicting stroke 7 and 90 days after visiting the emergency department using the original “high-risk” cutpoint of an ABCD2 score of more than 5, and the American Heart Association recommendation of a score of more than 2.Results:
We enrolled 2056 patients (mean age 68.0 yr, 1046 (50.9%) women) who had a rate of stroke of 1.8% at 7 days and 3.2% at 90 days. An ABCD2 score of more than 5 had a sensitivity of 31.6% (95% confidence interval [CI] 19.1–47.5) for stroke at 7 days and 29.2% (95% CI 19.6–41.2) for stroke at 90 days. An ABCD2 score of more than 2 resulted in sensitivity of 94.7% (95% CI 82.7–98.5) for stroke at 7 days with a specificity of 12.5% (95% CI 11.2–14.1). The accuracy of the ABCD2 score as calculated by either the enrolling physician (area under the curve 0.56; 95% CI 0.47–0.65) or the coordinating centre (area under the curve 0.65; 95% CI 0.57–0.73) was poor.Interpretation:
This multicentre prospective study involving patients in emergency departments with transient ischemic attack found the ABCD2 score to be inaccurate, at any cut-point, as a predictor of imminent stroke. Furthermore, the ABCD2 score of more than 2 that is recommended by the American Heart Association is nonspecific.There are approximately 100 visits to the emergency department per 100 000 population for transient ischemic attack each year.1 Although often considered benign, transient ischemic attack carries a risk of imminent stroke. Studies have shown that the risk of stroke is 0.2%–10% within 7 days of the first transient ischemic attack, and this risk increases to 1.2%–12% at 90 days.2–9 Stroke continues to be the leading cause of disability among adults and the third-leading cause of death in North America.10,11 Identifying people with transient ischemic attack who are at high risk of stroke is an opportunity to prevent stroke.3,4 However, urgent investigation of all transient ischemic attacks would require substantial resources. Three studies have attempted to develop clinical decision rules (i.e., scores) for assessing whether a patient with transient ischemic attack is at high risk of stroke.9,12,13 Combined, these studies led to the development of the ABCD2 (Age, Blood pressure, Clinical features, Duration of symptoms and Diabetes) score. However, despite its widespread implementation, the ABCD2 score has not yet been prospectively validated.12,14–18 This essential step in the development of rules for making clinical predictions has recently been requested.14,19–21The objective of this study was to externally validate the ABCD2 score as a tool for identifying patients seen in the emergency department with transient ischemic attack who are at high risk of stroke within 7 (primary outcome) and 90 days (one of the secondary outcomes). 相似文献946.
947.
948.
949.
Actin depolymerizing factors (ADFs) have been recently implicated in plant defense against pathogenic fungi, associated with the cytoskeletal rearrangements that contribute to establish an effective barrier against fungal ingress. In this work, we identified a DNA fragment corresponding to a part of a gene predicted to encode an ADF-like protein in genotypes of Fragaria ananassa resistant to the fungus Colletotrichum acutatum. Bulked segregant analysis combined with AFLP was used to identify polymorphisms linked to resistance in hybrids derived from the cross between the resistant cultivar 'Sweet Charlie' and the susceptible cultivar 'Pájaro'. The sequence of one out of three polymorphic bands detected showed significant BLASTX hits to ADF proteins from other plants. Two possible exons were identified and bioinformatic analysis revealed the presence of the ADF homology domain with two actin-binding sites, an N-terminal phosphorylation site, and a nuclear localization signal. In addition to its possible application in strawberry breeding programs, these finding may contribute to investigate the role of ADFs in plant resistance against fungi. 相似文献
950.
Although nitric oxide (NO) was identified more than 150 years ago and its effects were clinically tested in the form of nitroglycerine, it was not until the decades of 1970-1990 that it was described as a gaseous signal transducer. Since then, a canonical pathway linked to cyclic GMP (cGMP) as its quintessential effector has been established, but other modes of action have emerged and are now part of the common body of knowledge within the field. Classical (or canonical) signaling involves the selective activation of soluble guanylate cyclase, the generation of cGMP, and the activation of specific kinases (cGMP-dependent protein kinases) by this cyclic nucleotide. Nonclassical signaling alludes to the formation of NO-induced posttranslational modifications (PTMs), especially S-nitrosylation, S-glutathionylation, and tyrosine nitration. These PTMs are governed by specific biochemical mechanisms as well as by enzymatic systems. In addition, a less classical but equally important pathway is related to the interaction between NO and mitochondrial cytochrome c oxidase, which might have important implications for cell respiration and intermediary metabolism. Cross talk trespassing these necessarily artificial conceptual boundaries is progressively being identified and hence an integrated systems biology approach to the comprehension of NO function will probably emerge in the near future. 相似文献